Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
Balance Sheet
Inspect the capital base behind the business.
Assets
$596.19M
FY 2025 · Annual
+30.6% YoYLiabilities
$214.26M
FY 2025 · Annual
+486.9% YoYEquity
$381.93M
FY 2025 · Annual
-9.1% YoYBalance Sheet
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $167.1M |
| Short-term Investments | $311.5M |
| Receivables | $18.9M |
| Other Current | $9.9M |
| Total Current Assets | $507.3M |
| PP&E (Net) | $23.6M |
| Other Non-current | $88.4M |
| Total Non-current Assets | $112.1M |
| Total Assets | $619.4M |
Analysis
Selected assets total $619.4M for Latest. The largest visible component is Short-term Investments at $311.5M, about 50.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 9, 2026 | |
| 8-K | Current report | Nov 9, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 19, 2026 |
How much cash does SEPN have?
Septerna, Inc. (SEPN) reported $120.72M in cash and equivalents in fiscal 2025.
How much debt does SEPN carry?
Septerna, Inc. (SEPN) reported $23.63M of total debt, with net debt of -$97.10M.
Continue the stock analysis
Jump to another research area for this company.